http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017029353-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ef6d1f5841d1d0c6adbc6d3f2c58193 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-047 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-047 |
| filingDate | 2016-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d001e9f6d5ac61b2e59e4d138ce4385 |
| publicationDate | 2017-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017029353-A1 |
| titleOfInvention | Treatment of behaviors in dementia patients |
| abstract | The invention relates to methods for treating agitation,aggression, apathy and/or anxiety in dementia patients with moderate and severe disease comprising administering a scyllo-inositol compound, in particular scyllo-inositol,or a pharmaceutically acceptable salt thereof.In a method of the invention dementia patients with a selected NPI-C A+A score, in particular a score of at least or greater than 22, are treated for agitation and/or aggression with a scyllo-inositol compound, in particular scyllo-inositol,or a pharmaceutically acceptable salt thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019025934-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021038035-A1 |
| priorityDate | 2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.